Cell markers in the recognition of acute myeloblastic leukaemia subtypes

• Autorzy: Andoljsek D , Preloznik Zupan I. , Zontar D. , Cernelc P. , Mlakar U. , Modic M. , Pretnar J. , Zver S.
• Języki publikacji: EN

Abstrakty

EN

The diagnosis of acute myeloblastic leukaemia (AML) is based on cell morphology, cytogenetic and molecular changes, cell markers and clinical data. Our aim was to establish whether morphology and cell markers are comparable in the evaluation of AML. Bone marrow smears were analysed, and flow cytometry and monoclonal antibodies were used to determine cell type and maturity. Morphology and cell markers correlated differently in different AML subtypes.

Słowa kluczowe

EN

cell marker; acute myeloblastic leukemia phenotype; diagnosis; recognition; molecular change; acute myeloblastic leukemia subtype; cell morphology; cytogenetic change

• Wydawca: -
• Czasopismo: Cellular and Molecular Biology Letters
• Rocznik: 2002
• Tom: 07
• Numer: 2
• Opis fizyczny: p.343-345

Twórcy

autor

Andoljsek D

• University Medical Centre Ljubljana, Ljubljana, Slovenia

autor

Preloznik Zupan I.

autor

Zontar D.

autor

Cernelc P.

autor

Mlakar U.

autor

Modic M.

autor

Pretnar J.

autor

Zver S.

Bibliografia

• 1. Harris, N. L., Jaffe, E. S., Diebold, J., Fladrin, G., Mueller-Hermelink, H. K., Vardiman, J., Lister, T. A. and Bloomfield, C. D. WHO classification of neoplastic diseases of the hematopoetic and lymphoid tissues: report of the clinical advisory committee- Airlie House, Virginia, Movember 1997. J. Clin. Oncol. 17 (1999) 3835-3849.
• 2. Bene, M. C., Castoldi, G., Knapp, W., Ludwig, W. B., Matutes, E., Orfao, A. vant Veer MB (EGIL). Proposals for the immunological classification of acute leukemias. Leukemia 9 (1995) 1783-1786.
• 3. Cheson, B. D., Cassileth, P. A., Head, D. R., Schiffer, C. A., Bennett, J. M., Bloomfield, C. D., Brunning, R., Gale, R. P., Grever, M. R. and Keating, M. J. Report of National Cancer Institute sponsored workshop on definition of diagnosis and response in acute myeloid leukemia. J. Clin. Oncol. 8 (1990) 13-19.
• 4. Foon, K., Gale, R. P. and Todd, R. F. Recent advances in the immunologic classification of leukaemia. Sem. Haemat. 23 (1986) 257-283.
• 5. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A., Gralnick, H. R. and Sultan, C. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-M0). Br. J. Haematol. 78 (1991) 325-329.